Alzheimer’s & Dementia

Filter Your Results

 

News

 

Biases in Dementia Screening Tools

Wednesday, November 28, 2018—Brief cognitive tests are useful screening tools for dementia in the primary care setting; however, a study published in the journal Neurology Clinical Practice show…

Consuming Orange Juice, Leafy Greens, and Berries Is Related to Less Memory Loss in Men

Wednesday, November 21, 2018—A study published in Neurology states that eating leafy greens, dark orange and red vegetables, and berry fruits, and drinking orange juice is related to less memory…

New Campaign Urges Women to Take The Lead on Brain Health

Friday, November 16, 2018—A new campaign, Be Brain Powerful (bebrainpowerful.org), has been launched to encourage women to talk about brain health and take steps to preserve cognitive function has…

Study Confirms Benefits of Laser Interstitial Thermal Therapy

Wednesday, November 14, 2018—A prospective, multi-center clinical study of 42 patients with brain lesions that recurred after stereotactic radiosurgery (SRS) for metastatic brain tumors showed p…

Another Beta-Secretase 1 (BACE) Inhibitor Phase 3 Trial Stopped

Wednesday, November 07, 2018—A trial of investigational drugs LY3202626 and LY3002813 (also known as N3pG mAB) (BACE IV; Eli Lilly, Indianapolis, IN) in combination for patients with Alzheimer’s dis…

Positive Top-Line Results Announced from Phase 2 Study of Pimavanserin for Adjunctive Treatment of Major Depressive Disorder

Tuesday, October 30, 2018—Pimavanserin (Nuplazid; Acadia Pharmaceuticals, San Diego, CA), already approved for treatment of patients with Parkinson’s disease (PD) psychosis is also being studied …

Evidence Growing That Eyes May Be A Window to Alzheimer’s Diagnosis

Monday, October 29, 2018—Results presented at the 122ndAnnual Meeting of the American Academy of Ophthalmology suggest that optical coherence tomography (OCT) and OCT-angiography (OCTA) may be diagnos…

Positive Preliminary Phase 2 Clinical Trial Results for Bryostatin as Treatment for Alzheimer’s Disease

Wednesday, October 24, 2018—At the 11thEdition of Clinical Trials on Alzheimer’s Disease (CTAD) interim results were shared from a phase 2 trial (NCT03560245) evaluating the use of bryostatin (Neur…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC